Internal Medicine, Hematology & Oncology · Guaynabo, PR
NPI
1831300805
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
Pmb 182 A-9 Calle Tabonuco, Suite A - 9
Guaynabo, PR, 00968
Phone (787) 884-7202
Medicare paid, 2024
$266K
15,766 services
Medicare patients, 2024
37
Average age 76
Drug cost, 2024
$17.5M
4,712 prescriptions
Company payments, 2025
$6,958
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Santa M Merle was code 99213 (office e&m - established), 30 times for 21 patients. In total Santa M Merle billed 15,766 services in 34 codes, and Medicare paid $266K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 30 | 21 | $50.61 | $1,518 |
| 99214 Office E&M - Established | Office | 24 | 19 | $67.03 | $1,609 |
By year: 2022 $66K for 6,234 services; 2023 $229K for 24,320 services; 2024 $266K for 15,766 services.
Medicare prescription drug claims, 2024
In 2024, the drug Santa M Merle prescribed most often to Medicare patients was Anastrozole, with 711 prescriptions and refills. In total Santa M Merle wrote 4,712 Medicare prescriptions that cost $17.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 711 | 809 | 105 | $10K |
| Dexamethasone Generic | 149 | 151 | 66 | $1,654 |
| Exemestane Generic | 142 | 152 | 19 | $9,055 |
| Prednisone Generic | 134 | 134 | 38 | $743 |
| Aprepitant Generic | 130 | 130 | 29 | $79K |
| Lenalidomide Generic | 130 | 130 | 19 | $1.8M |
| Ibrance Palbociclib | 128 | 128 | 17 | $2.0M |
| Letrozole Generic | 116 | 130 | 18 | $1,426 |
| Ondansetron Odt Ondansetron | 108 | 108 | 73 | $757 |
| Famotidine Generic | 105 | 115 | 42 | $593 |
| Tamoxifen Citrate Generic | 103 | 103 | 12 | $1,869 |
| Retacrit Epoetin Alfa-Epbx | 96 | 96 | 48 | $72K |
| Inlyta Axitinib | 93 | 93 | Under 11 | $1.0M |
| Hydroxyurea Generic | 85 | 85 | 14 | $2,090 |
| Omeprazole Generic | 81 | 85 | 46 | $379 |
Brand drugs: 1,426 claims; generic drugs: 3,286 claims; opioid claims: 159.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Santa M Merle $6,958 ($6,958 in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbvie Inc. with $3,174.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $3,174 |
| AstraZeneca Pharmaceuticals LP AZN | 20 | $545 |
| Pbg Puerto Rico LLC | 19 | $462 |
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $387 |
| Merck Sharp & Dohme LLC MRK | 15 | $366 |
| Sobi, Inc SOBI.ST | 5 | $208 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $198 |
| Genentech USA, Inc. ROG.SW | 10 | $186 |
| Amgen Inc. AMGN | 8 | $181 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $170 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.